Clinical Trials Logo

Clinical Trial Summary

Giving women one day before and immediately after cesarean section a mouthly dissolving mosapride tablets 2every every 8 hours for maximum of 5 days ,or getting recovered gastrointestinal functions And assess preoperative gastrointestinal functions


Clinical Trial Description

Uncomplicated post cesarean women one day before and immediately after elective cesarean receive 2 mouthly dissolving mosapride tablets every 8 hours maximum for 5 days and clinical care giver follow the woman's gastrointestinal functions, including intraoperative and postoperative nausea vomiting, passing flatus, hearing intestinal sounds, passing stools, occurring of paralytic ileus, length of the hospital stay ;


Study Design


Related Conditions & MeSH terms

  • Prevention of Postoperative Ileus

NCT number NCT03477266
Study type Interventional
Source Benha University
Contact
Status Completed
Phase Phase 3
Start date April 1, 2018
Completion date August 1, 2018